Stryker Orthopaedics — Capital Expenditures During Period increased by 1.5% to $68.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 13.3%, from $60.00M to $68.00M. Over 2 years (FY 2022 to FY 2024), Orthopaedics — Capital Expenditures During Period shows an upward trend with a 15.3% CAGR.
An increase indicates investment in future capacity or efficiency, while a decrease may signal a focus on cash preservation or a mature asset base.
This measures the cash spent by the Orthopaedics segment to acquire, maintain, or upgrade physical assets such as manufa...
Standard capital expenditure reporting for business segments in manufacturing-heavy industries.
syk_segment_orthopaedics_capital_expenditures_during_period| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $43.25M | $43.25M | $43.25M | $43.25M | $44.75M | $44.75M | $44.75M | $44.75M | $65.00M | $46.00M | $60.00M | $59.00M | $34.00M | $67.00M | $68.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.5% | +0.0% | +0.0% | +0.0% | +45.3% | -29.2% | +30.4% | -1.7% | -42.4% | +97.1% | +1.5% |
| YoY Change | — | — | — | — | +3.5% | +3.5% | +3.5% | +3.5% | +45.3% | +2.8% | +34.1% | +31.8% | -47.7% | +45.7% | +13.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.